Anika Therapeutics, Inc. (ANIK) — DEFA14A Filings

All DEFA14A filings from Anika Therapeutics, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (1)

  • Anika Therapeutics Files Proxy Materials — Jun 25, 2024 Risk: low
    Anika Therapeutics, Inc. filed a Definitive Additional Materials (DEFA14A) on June 25, 2024. This filing is related to the company's proxy statement and does no

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.